Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 – Clinical Trial Not Allowed)

Funder: National Institutes of Health Due Date: 9/28/2018 Budget: $4,300,000 Opportunity: RFA-CA-18-003 http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-18-003.html This Funding Opportunity Announcement (FOA) solicits grant applications proposing exploratory research projects focused on further development and validation of emerging technologies…